SCHEMBL5980656

SCHEMBL5980656

O=NCCCN1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.54
KEAP1 Q14145 1/20 0.54
HPGD P15428 1/20 0.44
DUSP3 P51452 1/20 0.44
GLA P06280 1/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
GAA P10253 1/20 0.43
POLB P06746 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
LMNA P02545 2/20 0.42
PAOX Q6QHF9 1/20 0.40
KDM1A O60341 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6044315 0.86 GLA (0.47) SMN1; SMN2KEAP1HPGDDUSP3GLA
SCHEMBL1998867 0.83 KEAP1 (0.71) SMN1; SMN2KEAP1HPGDDUSP3GLA
SCHEMBL5910714 0.82 KEAP1 (0.58) SMN1; SMN2KEAP1HPGDDUSP3GLA
Ammonia Solution, Strong SCHEMBL9400430 0.81 KEAP1 (0.68) SMN1; SMN2KEAP1HPGDDUSP3GLA
SCHEMBL11222517 0.81 KEAP1 (0.68) SMN1; SMN2KEAP1HPGDDUSP3GLA
SCHEMBL11086634 0.79 HRH3 (0.52) SMN1; SMN2MAPK1ALDH1A1POLBLMNA
SCHEMBL952480 0.78 KEAP1 (0.54) SMN1; SMN2KEAP1HPGDDUSP3MAPK1
SCHEMBL7239607 0.78 KEAP1 (0.71) SMN1; SMN2KEAP1HPGDDUSP3GLA
SCHEMBL2181005 0.78 SMN1; SMN2 (0.48) SMN1; SMN2KEAP1HPGDDUSP3GLA
SCHEMBL6946106 0.78 SMN1; SMN2 (0.48) SMN1; SMN2KEAP1HPGDDUSP3GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-B1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF KANGPU BIOPHARMACEUTICALS LTD (CN) 2021-10-20 EP disclosed
WO-2012062745-A1 ALKOXY-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-05-18 WO disclosed
WO-2012062743-A1 ARYLAMINOALCOHOL-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINOLINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-05-18 WO disclosed